Positive Correlation of CRP and Fibrinogen Levels as Cardiovascular Risk Factors in Early Stage of Continuous Ambulatory Peritoneal Dialysis Patients

REFERENCES

• DOQ1 and NKF. Chronic kidney disease as a public health problem. Am J Kidney Dis. 2002; 39: 17–31
   Google Scholar
• Rattazzi M, Puato M, Faggin E, Bertipaglia B, Grego F, Pauletto P. New markers of accelerated atherosclerosis in end-stage renal disease. J Nephrol. 2003; 16: 11–20
   PubMed Web of Science ®Google Scholar
• Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2003; 41: 11–17
   PubMed Web of Science ®Google Scholar
• Dikow R, Adamczak M, Henriquez DE, Ritz E. Strategies to descrease cardiovascular mortality in patients with end-stage renal disease. Kidney Int. 2002; 61(Suppl. 80)5–10
   Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55: 648–658
   PubMed Web of Science ®Google Scholar
• Eren E, Yilmaz N, Pence S, et al. Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease. Acta Medica (Hradec Kralove). 2002; 45: 155–160
   Google Scholar
• Kim SB, Yang WS, Lee SK, Chi HS, Park JS. Effect of increasing serum albumin on haemostatic factors synthesized in the liver in CAPD patients. Nephrol Dial Transplant. 1998; 13: 2053–2058
   Google Scholar
• Jaradat MI, Molitoris BA. Cardiovascular disease in patiens with chronic kidney disease. Semin Nephrol. 2002; 22: 459–473
   PubMed Web of Science ®Google Scholar
• Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58: 353–362
   PubMed Web of Science ®Google Scholar
• Murphy SW, Foley RN, Parfrey PJ. National kidney foundation task force on cardiovascular disease: Screening and treatment for cardiovascular disease in patients with cronic renal disease. Am J Kidney Dis. 1998; 32: 184–199
   Google Scholar
• Partfey PS. Cardiac disease in dialysis patients: Diagnosis burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant. 2000; 15: 55–68
   Google Scholar
• Eikelboom JW, Hankey GJ. Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease. Curr Opin Nephrol Hypertens. 2001; 10: 377–383
   PubMed Web of Science ®Google Scholar
• Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we know? What do we need to learn? Where do we go from here?. Am J Kidney Dis. 1998; 32: 853–906
   PubMed Web of Science ®Google Scholar
• Speidl WS, Graf S, Hornykewycz S, et al. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J. 2002; 144: 449–455
   PubMed Web of Science ®Google Scholar
• Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortalitiy in haemodialysis patients. Nephrol Dial Transplant. 2002; 17: 29–32
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M, et al. Low grade inflammiation and coronary heart disease: Prospective study and updated metaanalyses. BMJ. 2000; 321: 199–204
   PubMed Web of Science ®Google Scholar
• Hayashi T, Suzuki A, Shoji T, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000; 35: 250–256
   PubMed Web of Science ®Google Scholar
• Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insuffieiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2001; 134: 629–636
   PubMed Web of Science ®Google Scholar
• Ridker PM, Stampfer MJ, Rifai N. Novel risk for systemic aterosclerosis. JAMA. 2001; 286: 2401–402
   Google Scholar
• Bergström J, Heimbürger O, Lindholm B, et al. Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in haemodialysis (HD) patients. J Am Soc Nephrol. 1995; 6: 573–581
   Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55: 1899–1911
   PubMed Web of Science ®Google Scholar
• Memoli B, Libetta C, Rampino T, et al. Interleukin-6 production ot ureamic haemodialysed patients: Effects of different membranes. Nephrol Dial Transplant. 1991; 2: 96–98
   Google Scholar
• Baigent C, Burbery K, Wheler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000; 356: 147–152
   PubMed Web of Science ®Google Scholar
• Biasucci LM. C-reactive protein and secondary prevention of coronary events. Clin Chim Acth. 2001; 311: 49–52
   Google Scholar
• Rifai N, Ridker PM. High senitivity C-reactive protein: A novel and promising marker of coranary heart disease. Clin Chem. 2001; 47: 403–411
   PubMed Web of Science ®Google Scholar
• Arnadottir M, Berg AL, Hegbrant J. Influence of haemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant. 1999; 14: 142–146
   PubMed Web of Science ®Google Scholar
• Bostom AG, Shemin D, Gohh R, Hultberg B. Treatment of hyperhomocysteinemia in hemodialysis patients renal transplant recipients. Kidney Int. 2001; 59: 246–252
   Google Scholar
• Koenig W. C-reactive protein and cardiovascular risk: An update on what is going on in cardiology. Nephrol Dial Transplant. 2003; 18: 1039–1041
   PubMed Web of Science ®Google Scholar
• Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet. 2003; 361: 827–833
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Heimburger O, Barany P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003; 41: 1212–1218
   PubMed Web of Science ®Google Scholar
• Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004; 15: 2186–2194
   PubMed Web of Science ®Google Scholar
• Herzig KA, Purdie DM, Chang W, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. J Am Soc Nephrol. 2001; 12: 814–821
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997; 29: 658–668
   PubMed Web of Science ®Google Scholar
• Borazan A, Aydemir S, Sert M, Yilmaz A. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Mediators Inflamm. 2004; 13: 361–364
   PubMedGoogle Scholar
• Borazan A, Ustun H, Ustundag Y, et al. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels. Mediators Inflamm. 2004; 13: 201–204
   PubMed Web of Science ®Google Scholar
• Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B. Association between inflammation and changes in residuel renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant. 2001; 16: 2240–2245
   PubMedGoogle Scholar
• Kronenberg F. Homocysteine, lipoprotein (a) and fibrinogen: Metabolic risk factors for cardiovascular complications of chronic renal disease. Curr Opin Nephrol Hypertens. 1998; 7: 271–278
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311: 501–505
   PubMed Web of Science ®Google Scholar
• Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999; 14: 1956–1960
   PubMed Web of Science ®Google Scholar